TapewireFind a company

person · Reporting owner

TESSLER ALLAN R

Disclosed activity across 6 companies

Tapewire entity
146087
SEC CIK
0000905084

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BioCardia, Inc.BCDA;BCDAW · Entity 7752DirectorJanuary 13, 2019August 23, 2019
STEEL PARTNERS HOLDINGS L.P.SPLP · Entity 51727DirectorMay 26, 2017May 26, 2017
TD AMERITRADE HOLDING CORPAMTD · Entity 146076DirectorOctober 06, 2020October 07, 2020
TEXAS PACIFIC LAND TRUSTTPL · Entity 14391710% ownerMarch 09, 2020March 11, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BioCardia, Inc.

Report date January 13, 2019 · Filed August 23, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect23,186 Ending reported balance After 2019-07-26 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2019-01-13 · Exercise / conversion · Acquired 567 · Balance 19,592

F1: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.

F3: The converted RSU corresponds to a 1:1 common stock issuance.

Row 2 · 2019-07-26 · Exercise / conversion · Acquired 3,594 · Balance 23,186

F2: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.

F3: The converted RSU corresponds to a 1:1 common stock issuance.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct4,161 Reported balance After 2019-01-13 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2019-01-13 · Exercise / conversion · Disposed 567 · Balance 4,161

F4: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct567 Reported balance After 2019-07-26 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2019-07-26 · Exercise / conversion · Disposed 3,594 · Balance 567

F4: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.

Common StockSEC Table I · non-derivativeIndirectSee footnote64,491 Reported balance Holding disclosure · report date 2019-01-13 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 64,491

F7: These shares are held by ART/FGT Family Limited Partnership, of which the Reporting Person and his spouse are limited partners.

Common StockSEC Table I · non-derivativeIndirectSee footnote13,009 Reported balance Holding disclosure · report date 2019-01-13 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 13,009

F8: These shares are held by International Financial Group, and the Reporting Person may be deemed to have beneficial ownership of such shares.

Common StockSEC Table I · non-derivativeIndirectSee footnote13,009 Reported balance Holding disclosure · report date 2019-01-13 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 13,009

F9: These shares are held by Tessler Family Limited Partnership, and the Reporting Person may be deemed to have beneficial ownership of such shares.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.

F2: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.

F3: The converted RSU corresponds to a 1:1 common stock issuance.

F4: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.

F6: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.

F7: These shares are held by ART/FGT Family Limited Partnership, of which the Reporting Person and his spouse are limited partners.

F8: These shares are held by International Financial Group, and the Reporting Person may be deemed to have beneficial ownership of such shares.

F9: These shares are held by Tessler Family Limited Partnership, and the Reporting Person may be deemed to have beneficial ownership of such shares.

STEEL PARTNERS HOLDINGS L.P.

Report date May 26, 2017 · Filed May 26, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Units no par valueSEC Table I · non-derivativeDirect43,836 Reported balance After 2017-05-26 transaction · row 1
1 source row

Row 1 · 2017-05-26 · Grant · Acquired 3,947 · Balance 43,836

F1: Restricted Common Units granted as of May 26, 2017 to the Reporting Person. The Restricted Common Units vest over three years in equal installments on each anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Common Units granted as of May 26, 2017 to the Reporting Person. The Restricted Common Units vest over three years in equal installments on each anniversary of the date of grant.

TD AMERITRADE HOLDING CORP

Report date October 06, 2020 · Filed October 07, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2020-10-06 transaction · row 1
1 source row

Row 1 · 2020-10-06 · Disposition to issuer · Disposed 72,973 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

Common StockSEC Table I · non-derivativeIndirectBy International Financial Group, Inc.0 Reported balance After 2020-10-06 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2020-10-06 · Disposition to issuer · Disposed 10,000 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

TEXAS PACIFIC LAND TRUST

Report date March 09, 2020 · Filed March 11, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Sub-share Certificates of Proprietary InterestSEC Table I · non-derivativeIndirectTessler Family LP1,700 Reported balance After 2020-03-09 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2020-03-09 · Purchase · Acquired 400 · Balance 1,700

F1: The Issuer's Sub-share Certificates of Proprietary Interest, par value $.03-1/3 (the "Shares") are held by Tessler Family LP. The general partner of Tessler Family LP is Apres Vous, LLC, a Wyoming limited liability company ("Apres LLC"). Andrea Tessler, Karla Tessler and Christopher Tessler, the children of Mr. Tessler, are the members of Apres LLC. Andrea Tessler and Karla Tessler are the managers of Apres LLC. Mr. Tessler is a partner and controls Tessler Family LP. Tessler Family LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to the such Shares. Mr. Tessler disclaims beneficial ownership of the 1,700 shares held by Tessler Family LP for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act"), except for his pecuniary interest therein.

F3: SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.

F4: Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 4 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.

Sub-share Certificates of Proprietary InterestSEC Table I · non-derivativeIndirectART-FGT Family Partners Limited10,830 Reported balance Holding disclosure · report date 2020-03-09 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 10,830

F2: The Shares are held by ART-FGT Family Partners Limited, a Wyoming limited partnership ("ART-FGT LP"). The general partner of ART-FGT LP is Tessler FMC, LLC, a Wyoming limited liability company ("Tessler LLC"). Mr. Tessler and his spouse, Frances G. Tessler, are the members of Tessler LLC. Andrea Tessler and Karla Tessler, daughters of Mr. Tessler, are the managers of Tessler LLC. Mr. Tessler is a partner and controls ART-FGT LP. ART-FGT LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to such Shares. Mr. Tessler disclaims beneficial ownership of the 10,830 Shares held by ART-FGT LP for purposes of Section 16 of the Act, except for his pecuniary interest therein. No transaction is reported. The amount of shares held indirectly through ART-FGT LP is included for informational purposes only.

F3: SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.

F4: Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 4 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.

Filing footnotes · ownership attribution and instrument terms

F1: The Issuer's Sub-share Certificates of Proprietary Interest, par value $.03-1/3 (the "Shares") are held by Tessler Family LP. The general partner of Tessler Family LP is Apres Vous, LLC, a Wyoming limited liability company ("Apres LLC"). Andrea Tessler, Karla Tessler and Christopher Tessler, the children of Mr. Tessler, are the members of Apres LLC. Andrea Tessler and Karla Tessler are the managers of Apres LLC. Mr. Tessler is a partner and controls Tessler Family LP. Tessler Family LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to the such Shares. Mr. Tessler disclaims beneficial ownership of the 1,700 shares held by Tessler Family LP for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act"), except for his pecuniary interest therein.

F2: The Shares are held by ART-FGT Family Partners Limited, a Wyoming limited partnership ("ART-FGT LP"). The general partner of ART-FGT LP is Tessler FMC, LLC, a Wyoming limited liability company ("Tessler LLC"). Mr. Tessler and his spouse, Frances G. Tessler, are the members of Tessler LLC. Andrea Tessler and Karla Tessler, daughters of Mr. Tessler, are the managers of Tessler LLC. Mr. Tessler is a partner and controls ART-FGT LP. ART-FGT LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to such Shares. Mr. Tessler disclaims beneficial ownership of the 10,830 Shares held by ART-FGT LP for purposes of Section 16 of the Act, except for his pecuniary interest therein. No transaction is reported. The amount of shares held indirectly through ART-FGT LP is included for informational purposes only.

F3: SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.

F4: Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 4 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Bath & Body Works, Inc.

Report date May 14, 2020 · Filed May 18, 2020

Section 16 reporting ended · disclosed 2020-05-18. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.50 par valueSEC Table I · non-derivativeDirect58,277 Reported balance After 2020-05-14 transaction · row 1
1 source row

Row 1 · 2020-05-14 · Grant · Acquired 4,574 · Balance 58,277

Common Stock, $0.50 par valueSEC Table I · non-derivativeIndirectBy Spouse3,500 Reported balance Holding disclosure · report date 2020-05-14 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 3,500

Common Stock, $0.50 par valueSEC Table I · non-derivativeIndirectBy Trust25,000 Reported balance Holding disclosure · report date 2020-05-14 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 25,000

Common Stock, $0.50 par valueSEC Table I · non-derivativeIndirectTessler Family Limited Partnership34,298 Reported balance Holding disclosure · report date 2020-05-14 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 34,298

IMPERVA INC

Report date January 10, 2019 · Filed January 11, 2019

Section 16 reporting ended · disclosed 2019-01-11. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote0 Reported balance After 2019-01-10 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2019-01-10 · Disposition to issuer · Disposed 34,103 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F2: The shares are owned of record as follows: (A) 2,353 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Common StockSEC Table I · non-derivativeIndirectSee Footnote0 Reported balance After 2019-01-10 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2019-01-10 · Disposition to issuer · Disposed 33,654 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F3: The shares are owned of record as follows: (A) 1,904 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Common StockSEC Table I · non-derivativeIndirectSee Footnote0 Reported balance After 2019-01-10 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 3 · 2019-01-10 · Disposition to issuer · Disposed 31,860 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F4: The shares are owned of record as follows: (A) 110 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2019-01-10 transaction · row 4
1 source row

Row 4 · 2019-01-10 · Disposition to issuer · Disposed 13,557 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2019-05-23Direct0 Reported balance After 2019-01-10 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2019-01-10 · Disposition to issuer · Disposed 4,081 · Balance 0

F5: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6: Pursuant to the Issuer's 2011 Stock Option and Incentive Plan and the Merger Agreement, the RSUs vested in full immediately prior to the closing of the merger, and were cancelled and converted into the right to receive $55.75 in cash per RSU.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.16 · Expires 2025-02-03Direct0 Reported balance After 2019-01-10 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2019-01-10 · Disposition to issuer · Disposed 6,380 · Balance 0

F7: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $86,704.20, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.35 · Expires 2025-05-05Direct0 Reported balance After 2019-01-10 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2019-01-10 · Disposition to issuer · Disposed 3,075 · Balance 0

F8: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $31,980.00, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F2: The shares are owned of record as follows: (A) 2,353 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

F3: The shares are owned of record as follows: (A) 1,904 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

F4: The shares are owned of record as follows: (A) 110 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

F5: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6: Pursuant to the Issuer's 2011 Stock Option and Incentive Plan and the Merger Agreement, the RSUs vested in full immediately prior to the closing of the merger, and were cancelled and converted into the right to receive $55.75 in cash per RSU.

F7: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $86,704.20, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

F8: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $31,980.00, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 06, 2020 Filed Oct 7, 2020 18:02 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 Disposition to issuerCommon Stock 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001173431-20-000172 · wf-form4_160210812197707.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By International Financial Group, Inc.

Disclosed balance after: 0

F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2 · shares: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2 · price: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

Read SEC document
October 06, 2020 Filed Oct 7, 2020 18:02 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 Disposition to issuerCommon Stock 72,973 Not disclosed Not disclosed
Disclosure

SEC source: 0001173431-20-000172 · wf-form4_160210812197707.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2 · shares: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 24, 2019 (as amended, the "Merger Agreement"), by and among The Charles Schwab Corporation ("Schwab"), Americano Acquisition Corp., a wholly owned subsidiary of Schwab ("Merger Sub"), and TD Ameritrade Holding Corporation ("TD Ameritrade"), pursuant to which Merger Sub merged with and into TD Ameritrade, with TD Ameritrade continuing as the surviving corporation and as a wholly owned subsidiary of Schwab (the "Merger"), on October 6, 2020 (the "Closing Date"). Pursuant to the Merger Agreement, each share of TD Ameritrade common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time") (other than certain shares held by Schwab, TD Ameritrade or The Toronto-Dominion Bank and its affiliates) was converted into the right to receive 1.0837 shares (the "Exchange Ratio") of Schwab common stock (the "Merger Consideration"). (Continued in footnote 2.)

F2 · price: The closing price per share of Schwab common stock on the NYSE on the Closing Date was $36.75. In addition, pursuant to the Merger Agreement, at the Effective Time, each outstanding TD Ameritrade time-vesting restricted stock unit (including each deferred restricted stock unit award and each stock unit issued in respect of deferred cash fees) outstanding under the TD Ameritrade 2006 Directors Incentive Plan, as amended from time to time, (a "TD Ameritrade Director RSU") was vested (if unvested) and converted into the right to receive the Merger Consideration, as if such TD Ameritrade Director RSU had been settled immediately prior to the Effective Time.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 18:15 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 24 $0.00 $0.00
Disclosure

SEC source: 0001173431-20-000129 · wf-form4_159839372686275.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,973

Read SEC document
May 20, 2020 Filed May 22, 2020 18:18 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 26 $0.00 $0.00
Disclosure

SEC source: 0001173431-20-000091 · wf-form4_159018589437895.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,949

Read SEC document
May 14, 2020 Filed May 18, 2020 22:51 UTC Bath & Body Works, Inc. LB · Entity 4091 GrantCommon Stock, $0.50 par value 4,574 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007980 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,277

Read SEC document
March 09, 2020 Filed Mar 11, 2020 17:02 UTC TEXAS PACIFIC LAND TRUST TPL · Entity 143917 PurchaseSub-share Certificates of Proprietary Interest 400 $498.00 $199,200.00
Disclosure

SEC source: 0001140361-20-005508 · form4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Tessler Family LP

Disclosed balance after: 1,700

F1 · ownership.nature: The Issuer's Sub-share Certificates of Proprietary Interest, par value $.03-1/3 (the "Shares") are held by Tessler Family LP. The general partner of Tessler Family LP is Apres Vous, LLC, a Wyoming limited liability company ("Apres LLC"). Andrea Tessler, Karla Tessler and Christopher Tessler, the children of Mr. Tessler, are the members of Apres LLC. Andrea Tessler and Karla Tessler are the managers of Apres LLC. Mr. Tessler is a partner and controls Tessler Family LP. Tessler Family LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to the such Shares. Mr. Tessler disclaims beneficial ownership of the 1,700 shares held by Tessler Family LP for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act"), except for his pecuniary interest therein.

F3 · ownership.nature: SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.

F4 · ownership.nature: Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 4 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.

Read SEC document
February 24, 2020 Filed Feb 26, 2020 16:26 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 5,243 $0.00 $0.00
Disclosure

SEC source: 0001173431-20-000052 · wf-form4_158275239463095.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,923

Read SEC document
February 19, 2020 Filed Feb 21, 2020 16:48 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 16 $0.00 $0.00
Disclosure

SEC source: 0001173431-20-000025 · wf-form4_158232170750122.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,680

Read SEC document
November 19, 2019 Filed Nov 21, 2019 16:22 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 20 $0.00 $0.00
Disclosure

SEC source: 0001173431-19-000147 · wf-form4_157437131375063.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,664

Read SEC document
October 04, 2019 Filed Oct 8, 2019 09:43 UTC TEXAS PACIFIC LAND TRUST TPL · Entity 143917 PurchaseSub-share Certificates of Proprietary Interest 500 $603.86 $301,930.00
Disclosure

SEC source: 0001140361-19-018103 · form4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · ART-FGT Family Partners Limited

Disclosed balance after: 10,830

F1 · ownership.nature: The Issuer's Sub-share Certificates of Proprietary Interest, par value $.03-1/3 (the "Shares") are held by ART-FGT Family Partners Limited, a Wyoming limited partnership ("ART-FGT LP"). The general partner of ART-FGT LP is Tessler FMC, LLC, a Wyoming limited liability company ("Tessler LLC"). Mr. Tessler and his spouse, Frances G. Tessler, are the members of Tessler LLC. Andrea Tessler and Karla Tessler, daughters of Mr. Tessler, are the managers of Tessler LLC. Mr. Tessler is a partner and controls ART-FGT LP. ART-FGT LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to such Shares. Mr. Tessler disclaims beneficial ownership of the 10,830 Shares held by ART-FGT LP for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act"), except for his pecuniary interest therein.

F3 · ownership.nature: SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.

F4 · ownership.nature: Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 3 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.

Read SEC document
August 20, 2019 Filed Aug 22, 2019 16:28 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 18 $0.00 $0.00
Disclosure

SEC source: 0001173431-19-000112 · wf-form4_156650567807867.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,644

Read SEC document
August 06, 2019 Filed Aug 8, 2019 16:41 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 PurchaseWarrant (right to buy) · Derivative 16,871 Not disclosed Strike: $6.30 Not disclosed
Disclosure

SEC source: 0001437749-19-016064 · rdgdoc.xml · derivative · entry 7

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,871

Underlying: Common Stock · 16,871 shares

Expires 2024-08-06

F1 · shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 16:41 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 ConversionConvertible promissory note · Derivative Not disclosed $0.00 Strike: $3.00 $50,000.00
Disclosure

SEC source: 0001437749-19-016064 · rdgdoc.xml · derivative · entry 6

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 16,871 shares

Expires 2020-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · reported_value: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 16:41 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 ConversionCommon Stock 16,871 $3.00 $50,613.00
Disclosure

SEC source: 0001437749-19-016064 · rdgdoc.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

Read SEC document
July 26, 2019 Filed Aug 23, 2019 06:32 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 Exercise / conversionRestricted Stock Units · Derivative 3,594 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-19-017334 · rdgdoc.xml · derivative · entry 7

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 567

Underlying: Common Stock · 3,594 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.

F6 · derivative.expiration_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.

Read SEC document
July 26, 2019 Filed Aug 23, 2019 06:32 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 Exercise / conversionCommon Stock 3,594 $0.00 $0.00
Disclosure

SEC source: 0001437749-19-017334 · rdgdoc.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.

F3 · price: The converted RSU corresponds to a 1:1 common stock issuance.

Read SEC document
July 05, 2019 Filed Aug 8, 2019 16:41 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 PurchaseConvertible promissory note · Derivative Not disclosed $50,000.00 Strike: $8.00 $50,000.00
Disclosure

SEC source: 0001437749-19-016064 · rdgdoc.xml · derivative · entry 5

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 6,250 shares

Expires 2020-01-05

F1 · derivative.exercise_price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · reported_value: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

Read SEC document
May 21, 2019 Filed May 23, 2019 16:27 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001173431-19-000074 · wf-form4_155864326115343.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,626

Read SEC document
March 28, 2019 Filed Apr 3, 2019 00:49 UTC Bath & Body Works, Inc. LB · Entity 4091 GrantCommon Stock, $0.50 par value 6,063 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-006231 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,703

Read SEC document
February 20, 2019 Filed Feb 21, 2019 16:40 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 2,602 $0.00 $0.00
Disclosure

SEC source: 0001173431-19-000037 · wf-form4_155078520737470.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,612

Read SEC document
February 19, 2019 Filed Feb 21, 2019 16:40 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001173431-19-000037 · wf-form4_155078520737470.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,010

Read SEC document
January 13, 2019 Filed Aug 23, 2019 06:32 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 Exercise / conversionRestricted Stock Units · Derivative 567 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-19-017334 · rdgdoc.xml · derivative · entry 6

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,161

Underlying: Common Stock · 567 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.

F5 · derivative.expiration_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.

Read SEC document
January 13, 2019 Filed Aug 23, 2019 06:32 UTC BioCardia, Inc. BCDA;BCDAW · Entity 7752 Exercise / conversionCommon Stock 567 $0.00 $0.00
Disclosure

SEC source: 0001437749-19-017334 · rdgdoc.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.

F3 · price: The converted RSU corresponds to a 1:1 common stock issuance.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerStock Option (right to buy) · Derivative 3,075 $0.00 Strike: $45.35 $0.00
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · derivative · entry 7

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,075 shares

Expires 2025-05-05

F8 · derivative.exercise_date: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $31,980.00, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerStock Option (right to buy) · Derivative 6,380 $0.00 Strike: $42.16 $0.00
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · derivative · entry 6

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,380 shares

Expires 2025-02-03

F7 · derivative.exercise_date: Shares subject to the option are fully vested. Pursuant to the Merger Agreement, the option was cancelled and converted into the right to receive a cash payment of $86,704.20, which represents the difference between $55.75 and the exercise price of the option per share multiplied by the number of shares subject to the option.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerRestricted Stock Units · Derivative 4,081 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · derivative · entry 5

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,081 shares

Expires 2019-05-23

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6 · derivative.exercise_date: Pursuant to the Issuer's 2011 Stock Option and Incentive Plan and the Merger Agreement, the RSUs vested in full immediately prior to the closing of the merger, and were cancelled and converted into the right to receive $55.75 in cash per RSU.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerCommon Stock 13,557 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · nonDerivative · entry 4

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerCommon Stock 31,860 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · nonDerivative · entry 3

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F4 · ownership.nature: The shares are owned of record as follows: (A) 110 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerCommon Stock 33,654 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F3 · ownership.nature: The shares are owned of record as follows: (A) 1,904 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:08 UTC IMPERVA INC IMPV · Entity 161103 Disposition to issuerCommon Stock 34,103 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-003483 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger between the Issuer, Imperial Purchaser, LLC and Imperial Merger Sub, Inc. dated October 10, 2018 (the "Merger Agreement"), the shares of common stock were cancelled and converted into the right to receive $55.75 in cash per share, payable as otherwise provided by the terms of the Merger Agreement.

F2 · ownership.nature: The shares are owned of record as follows: (A) 2,353 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
December 19, 2018 Filed Dec 20, 2018 17:31 UTC IMPERVA INC IMPV · Entity 161103 GiftCommon Stock 1,794 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063716 · doc4.xml · nonDerivative · entry 3

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 31,860

F6 · kind: Bona fide gift by the Reporting Person of 1,794 shares to the Grand Teton Music Festival.

F6 · shares: Bona fide gift by the Reporting Person of 1,794 shares to the Grand Teton Music Festival.

F2 · price: Price is not applicable to acquisitions or dispositions resulting from a bona fide gift.

F7 · ownership.nature: The shares are owned of record as follows: (A) 110 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 17:31 UTC IMPERVA INC IMPV · Entity 161103 GiftCommon Stock 449 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063716 · doc4.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 33,654

F4 · kind: Bona fide gift by the Reporting Person of 449 shares to the Hudson Institue.

F4 · shares: Bona fide gift by the Reporting Person of 449 shares to the Hudson Institue.

F2 · price: Price is not applicable to acquisitions or dispositions resulting from a bona fide gift.

F5 · ownership.nature: The shares are owned of record as follows: (A) 1,904 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 17:31 UTC IMPERVA INC IMPV · Entity 161103 GiftCommon Stock 897 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063716 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 34,103

F1 · kind: Bona fide gift by the Reporting Person of 897 shares to the Trust for Public Land.

F1 · shares: Bona fide gift by the Reporting Person of 897 shares to the Trust for Public Land.

F2 · price: Price is not applicable to acquisitions or dispositions resulting from a bona fide gift.

F3 · ownership.nature: The shares are owned of record as follows: (A) 2,353 shares are held by International Financial GP of Nevada, of which the Reporting Person is the sole owner and Chair/CEO; (B) 7,500 shares are held by the Allan R. Tessler Charitable Remainder Unitrust #1 u/a/d 121696, of which the Reporting Person is the sole trustee; (C) 7,500 Shares are held by the Allan R. Tessler Charitable Remainder Unitrust #2 u/a/d 121696, of which the Reporting Person is the sole trustee; (D) 6,750 shares are held by Tessler Family Limited of which the Reporting Person is a limited partner; and (E) 10,000 shares are held by the ART FGT Family Partners Limited, of which the Reporting Person is a limited partner.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 16:27 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001173431-18-000161 · wf-form4_154283561547960.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,998

Read SEC document
August 21, 2018 Filed Aug 23, 2018 16:28 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001173431-18-000117 · wf-form4_153505612174408.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,985

Read SEC document
July 26, 2018 Filed Sep 26, 2018 21:17 UTC BioCardia, Inc. BCDA · Entity 7752 GrantRestricted Stock Units · Derivative 32,353 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-18-017509 · rdgdoc.xml · derivative · entry 8

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,353

Underlying: Common Stock · 32,353 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F13 · derivative.exercise_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019.

F13 · derivative.expiration_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019.

Read SEC document
June 15, 2018 Filed Sep 26, 2018 21:17 UTC BioCardia, Inc. BCDA · Entity 7752 Exercise / conversionRestricted Stock Units · Derivative 9,166 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-18-017509 · rdgdoc.xml · derivative · entry 7

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on June 15, 2018 was $1.40 per share.

F12 · derivative.exercise_date: On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017), which vested on June 15, 2018. The common stock into which such vested RSUs converted on June 15, 2018 is reported on Table I of this Form 4.

F12 · derivative.expiration_date: On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017), which vested on June 15, 2018. The common stock into which such vested RSUs converted on June 15, 2018 is reported on Table I of this Form 4.

Read SEC document
June 15, 2018 Filed Sep 26, 2018 21:17 UTC BioCardia, Inc. BCDA · Entity 7752 Exercise / conversionCommon Stock 9,166 $0.00 $0.00
Disclosure

SEC source: 0001437749-18-017509 · rdgdoc.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,277

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the conversion upon vesting of RSUs into common stock. On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the SEC on August 25, 2017.

F7 · price: The converted RSU corresponds to a 1:1 common stock issuance.

Read SEC document
May 22, 2018 Filed May 24, 2018 16:20 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001173431-18-000078 · wf-form4_152719317986656.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,977

Read SEC document
April 26, 2018 Filed Apr 26, 2018 19:35 UTC IMPERVA INC IMPV · Entity 161103 Exercise / conversionRestricted Stock Units · Derivative 4,624 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-026323 · doc4.xml · derivative · entry 4

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,624 shares

Expires 2018-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6 · derivative.exercise_date: The restricted stock units vest as follows: 100% of the underlying shares vest one year following the vesting commencement date of April 26, 2017. The restricted stock units are subject to accelerated vesting as to 100% of such shares following a change in control of the Issuer.

F5 · derivative.expiration_date: The Issuer has up to 30 days following vesting to settle. The actual expiration date will be immediately following settlement.

Read SEC document
April 26, 2018 Filed Apr 26, 2018 19:35 UTC IMPERVA INC IMPV · Entity 161103 Exercise / conversionCommon Stock 4,624 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-026323 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of shares that were acquired in connection with the settlement of the restricted stock units listed in Table II.

Read SEC document
April 24, 2018 Filed Apr 26, 2018 19:35 UTC IMPERVA INC IMPV · Entity 161103 GrantRestricted Stock Units · Derivative 4,081 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-026323 · doc4.xml · derivative · entry 3

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,081

Underlying: Common Stock · 4,081 shares

Expires 2019-05-23

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F4 · derivative.exercise_date: The restricted stock units vest as follows: 100% of the underlying shares vest one year following the vesting commencement date of April 24, 2018. The restricted stock units are subject to accelerated vesting as to 100% of such shares following a change in control of the Issuer.

F5 · derivative.expiration_date: The Issuer has up to 30 days following vesting to settle. The actual expiration date will be immediately following settlement.

Read SEC document
March 21, 2018 Filed Mar 23, 2018 20:47 UTC Bath & Body Works, Inc. LB · Entity 4091 GrantCommon Stock, $0.50 par value 4,298 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-006642 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,640

Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:44 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GiftCommon Stock 3,835 $0.00 $0.00
Disclosure

SEC source: 0001173431-18-000037 · wf-form4_151933587103737.xml · nonDerivative · entry 2

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,970

Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:44 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 2,343 $0.00 $0.00
Disclosure

SEC source: 0001173431-18-000037 · wf-form4_151933587103737.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,805

Read SEC document
February 02, 2018 Filed Feb 5, 2018 16:59 UTC IMPERVA INC IMPV · Entity 161103 Exercise / conversionRestricted Stock Units · Derivative 1,028 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-007557 · doc4.xml · derivative · entry 3

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,028 shares

Expires 2018-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F4 · derivative.exercise_date: The restricted stock units vest as follows: one-third of the underlying shares vest one year following the vesting commencement date of February 2, 2015 with the remaining two-thirds vesting in equal annual installments over the next two years. The restricted stock units are subject to accelerated vesting as to 100% of such shares following a change in control of the Issuer.

F5 · derivative.expiration_date: The Issuer has up to 30 days following vesting to settle. The actual expiration date will be immediately following settlement.

Read SEC document
February 02, 2018 Filed Feb 5, 2018 16:59 UTC IMPERVA INC IMPV · Entity 161103 Exercise / conversionCommon Stock 1,028 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-007557 · doc4.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of shares that were acquired in connection with the settlement of the restricted stock units listed in Table II.

Read SEC document
January 13, 2018 Filed Sep 26, 2018 21:17 UTC BioCardia, Inc. BCDA · Entity 7752 Exercise / conversionRestricted Stock Units · Derivative 5,111 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-18-017509 · rdgdoc.xml · derivative · entry 6

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,222

Underlying: Common Stock · 10,222 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on January 12, 2018 was $2.95 per share.

F11 · derivative.exercise_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017), of which 5,111 vested on January 13, 2018. The common stock into which such vested RSUs converted on January 13, 2018 is reported on Table I of this Form 4. The remaining RSUs will continue to vest on the second and third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.

F11 · derivative.expiration_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017), of which 5,111 vested on January 13, 2018. The common stock into which such vested RSUs converted on January 13, 2018 is reported on Table I of this Form 4. The remaining RSUs will continue to vest on the second and third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
January 13, 2018 Filed Sep 26, 2018 21:17 UTC BioCardia, Inc. BCDA · Entity 7752 Exercise / conversionCommon Stock 5,111 $0.00 $0.00
Disclosure

SEC source: 0001437749-18-017509 · rdgdoc.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.

F6 · price: The converted RSU corresponds to a 1:1 common stock issuance.

Read SEC document
November 21, 2017 Filed Nov 22, 2017 16:34 UTC TD AMERITRADE HOLDING CORP AMTD · Entity 146076 GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001173431-17-000182 · wf-form4_151138646283515.xml · nonDerivative · entry 1

TESSLER ALLAN R · CIK 0000905084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,462

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.